techcrunch.com
Oct 14, 2026
Colossal Biosciences announces new AI platform to help accelerate de-extinction efforts
AI-summarised brief · reviewed before publication
Colossal Biosciences unveiled GenoMorph, an AI platform that integrates 3D morphology, comparative genomics, and developmental biology to pinpoint gene edits for de‑extinction projects with scarce DNA. The tool, built over a year using data from over 70 bird species, has identified roughly 2,300 candidate targets for restoring the dodo’s cranial features. The company also announced progress in its Nicobar pigeon colony, producing essential germ cells, and introduced a lipid‑nanoparticle delivery system for rapid embryonic testing. The platform received endorsement from XPRIZE founder Peter Diamandis, who launched NeoGenesis Capital to fund related ventures.
💡 Why It Matters
- · GenoMorph narrows the genetic search space, accelerating de‑extinction timelines and reducing experimental costs.
- · Its precision could set a new standard for responsible genome editing across conservation and biotechnology.
